Eisai
4523.T
#2184
Rank
ยฃ6.35 B
Marketcap
ยฃ22.51
Share price
0.11%
Change (1 day)
-1.87%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ2.83 Billion

According to Eisai's latest financial reports the company's total liabilities are ยฃ2.83 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31ยฃ2.68 B3.91%
2024-03-31ยฃ2.58 B-3.39%
2023-03-31ยฃ2.67 B-8.39%
2022-03-31ยฃ2.92 B23.23%
2021-03-31ยฃ2.37 B-12.01%
2020-03-31ยฃ2.69 B-7.15%
2019-03-31ยฃ2.90 B-0.41%
2018-03-31ยฃ2.91 B-5.02%
2017-03-31ยฃ3.06 B24.84%
2016-03-31ยฃ2.45 B-3.17%
2015-03-31ยฃ2.53 B-1.76%
2014-03-31ยฃ2.58 B-28.26%
2013-03-31ยฃ3.60 B-17.87%
2012-03-31ยฃ4.38 B-7.84%
2011-03-31ยฃ4.75 B0.39%
2010-03-31ยฃ4.73 B-5.45%
2009-03-31ยฃ5.01 B53.69%
2008-03-31ยฃ3.26 B228.56%
2007-03-31ยฃ0.99 B-11.37%
2006-03-31ยฃ1.11 B11.85%
2005-03-31ยฃ1.00 B-1.77%
2004-03-31ยฃ1.01 B-6.99%
2003-03-31ยฃ1.09 B11.71%
2002-03-31ยฃ0.98 B-13.64%
2001-03-31ยฃ1.13 B